Skip to content

Comparison of visual outcomes, spectacles dependence and patient satisfaction after implantation of SN6AD1, SN6AD3, FIL611PV and FIL618 intraocular lenses for cataract surgery

Visual acuity, additional correction reduction (for close-up and intermediate distances), visual disturbances rate, spectacles dependence, quality of life and personal satisfaction after phacoemulsification and implantation of SN6AD1, SN6AD3, FIL611PV and FIL618 intraocular lenses in patients affected by bilateral cataract

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN14145737
Enrollment
60
Registered
2017-02-02
Start date
2013-04-01
Completion date
Unknown
Last updated
2017-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataracts Eye Diseases Cataracts

Interventions

Participants are allocated to one of four different arms (SN6AD1 group, SN6AD3 group, FIL611PV group and FIL618 group) by block randomization. All participants receive a complete ophthalmological preo

Sponsors

Institute of Ophthalmology
Lead Sponsor
San Luigi Gonzaga University Hospital
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged over 50 years 2. Bilateral cataract 3. Maximum regular corneal astigmatism of 1.0 D

Exclusion criteria

Exclusion criteria: 1. Optical means opacities different from cataract 2. Age-related macular degeneration 3. Previous history of ocular surgery 4. Irregular corneal astigmatism 5. Amblyopy 6. Concurrent neuro-muscular diseases (i.e. cerebral ictus, myasthenia) 7. Uncontrolled open/close-angle glaucoma 8. Severe ocular complications related to diabetes (i.e. retinopathy, macular edema, vitreal hemorrhage) 9. Intra/postoperative complications 10. Pupil diameter = 5,2 mm in mesopic lighting conditions measured with a slit lamp-based cobalt blue light method

Design outcomes

Primary

MeasureTime frame
1. Postoperative uncorrected and best-corrected visual acuity for far distances is assessed with LogMar and ETDRS charts for each eye at 1 day, 7 days, 1 month, 3 months and 6 months 2. Postoperative uncorrected and best-corrected visual acuity for intermediate distances (60 cm) is assessed using the Jeager eye chart for each eye at 1 day, 7 days, 1 month, 3 months and 6 months 3. Postoperative uncorrected and best-corrected visual acuity for near distances (33cm) is assessed using the Jaeger eye chart for each eye at 1 day, 7 days, 1 month, 3 months and 6 months 4. Additional correction (diopters), in order to achieve best-corrected binocular visual acuity at intermediate and near distances, assessed with trial lenses during visual acuity examination with Jaeger eye chart for both eyes at the preoperative time and 6 months after surgery

Secondary

MeasureTime frame
1. Rate of visual disturbances (glare, difficulties in night vision, difficulties in colour perception, difficulties in depth perception, halos, distorted close-up vision, distorted vision for far distances, obscured close-up vision, obscured vision for far distances, doubled vision) is assessed by patient questionnaires with scores from 0 (for absence of disturbances) to 5 (for maximal difficulty) designed for the purpose of this study at six months after surgery (follow-up visit) 2. Spectacle dependence rate at intermediate and close-up distances is assessed by a patient questionnaire with scores from 0 (total independence) to 5 (for maximal dependence) designed for the purpose of this study at six months after surgery (follow-up visit) 3. Global visual satisfaction is assessed by a patient questionnaire with scores from 0 (totally unsatisfied) to 5 (totally satisfied) designed for the purpose of this study at six months after surgery (follow-up visit) 4. Difficulties in everyday activities is assessed using a patient questionnaire with scores from 0 (no difficulties) to 5 (for maximal difficulty) designed for the purpose of this study at six months after surgery (follow-up visit) FIL618 IOL Group only (measured in each eye): 1. Surgical capsulorhexis diameter is measured using a mm caliper applied on the excised portion of the capsular bag at the end of the capsulorhexis procedure (in course of surgical intervention) 2. Ocular axial length is measured using IOL Master and/or Ultrasound contact biometry at pre-surgical evaluation 3. Preoperative visual defect measured with Automatic refractometry at pre-surgical evaluation

Countries

Italy

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 27, 2026